Mette Julsgaard Selected Research

Inflammatory Bowel Diseases (Inflammatory Bowel Disease)

1/2024	Preterm Birth and in Utero Exposure to Corticosteroids Are Associated With Increased Infection Risk in Children of Mothers With IBD.
7/2023	Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
12/2022	Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children.
10/2022	Normal Sperm DNA Integrity in Patients With Inflammatory Bowel Disease on Ustekinumab Maintenance Therapy.
9/2022	Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study].
1/2022	Anti-TNFα Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy: A Case Series.
11/2021	Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study.
1/2020	Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
1/2020	Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.
4/2019	Semen Quality and Sperm DNA Integrity in Patients With Severe Active Inflammatory Bowel Disease and Effects of Tumour Necrosis Factor-alpha Inhibitors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mette Julsgaard Research Topics

Disease

18	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 02/2014
5	Infections 01/2024 - 04/2013
4	Ulcerative Colitis 03/2024 - 01/2019
4	Inflammation (Inflammations) 11/2023 - 01/2017
2	Necrosis 04/2024 - 04/2019
2	Crohn Disease (Crohn's Disease) 07/2023 - 01/2019
2	Stillbirth 04/2023 - 09/2022
2	Birth Weight (Birth Weights) 04/2023 - 01/2020
2	Spontaneous Abortion (Miscarriage) 09/2022 - 11/2021
1	Premature Birth (Birth, Premature) 01/2024
1	Pneumonia (Pneumonitis) 12/2023
1	Sepsis (Septicemia) 12/2023
1	Neoplasms (Cancer) 07/2023
1	Melanoma (Melanoma, Malignant) 07/2023
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 04/2023
1	Sialadenitis 10/2017
1	Colitis 01/2017
1	Serum Sickness 06/2013
1	Chickenpox 04/2013

Drug/Important Bio-Agent (IBA)

6	Infliximab (Remicade)FDA Link 03/2024 - 06/2013
4	Adalimumab (Humira)FDA Link 12/2022 - 04/2013
4	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2019
4	vedolizumabIBA 11/2021 - 01/2018
3	Ustekinumab (CNTO 1275)FDA Link 01/2024 - 10/2022
2	SteroidsIBA 01/2024 - 10/2018
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2023 - 01/2017
2	C-Reactive ProteinIBA 11/2023 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 01/2019
2	2-mercaptopurineIBA 01/2019 - 01/2016
1	Attenuated VaccinesIBA 04/2024
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2024
1	Janus KinasesIBA 02/2024
1	Janus Kinase InhibitorsIBA 02/2024
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 02/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024
1	Immunologic Factors (Immunomodulators)IBA 01/2024
1	Azathioprine (Imuran)FDA LinkGeneric 12/2023
1	tofacitinibIBA 08/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2019
1	Prostaglandins AIBA 01/2017

Therapy/Procedure

8	Therapeutics 10/2022 - 01/2016
2	Cesarean Section (Caesarean Section) 04/2023 - 09/2022
1	Colectomy 03/2024
1	Transplantation 07/2023
1	Organ Transplantation 07/2023